For example, decitabine reverses TGF-β-induced EMT in gastric cancer cells [60] and in PC9 non-small cell lung cancer cells [61] by reducing aberrant TGF-β-induced hypermethylation of the miR-200 gene promoter. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.